Alkermes (ALKS) Prepaid Assets (2011 - 2026)
Alkermes' (ALKS) quarterly Prepaid Assets came in at $102.4 million in Q1 2026, up 14.03% year-on-year from $89.8 million in Q1 2025, and up 29.53% on a QoQ basis from $79.1 million in Q4 2025.
Alkermes (ALKS) Prepaid Assets (2011 - 2026) Analysis & Trends
Alkermes (ALKS) has 16 years of Prepaid Assets data on file, last reported at $102.4 million in Q1 2026.
- On a quarterly basis, Prepaid Assets rose 14.03% year-over-year to $102.4 million in Q1 2026; TTM through Mar 2026 was $102.4 million, a 14.03% increase from a year earlier, with the FY2025 full-year figure at $79.1 million, down 13.36% from the prior year.
- Prepaid Assets for Q1 2026 stood at $102.4 million, up from $79.1 million in the prior quarter.
- Over the last five years, Prepaid Assets for ALKS reached as high as $111.5 million in Q1 2024 and fell as low as $40.0 million in Q3 2022.
- Historically, Prepaid Assets has averaged $73.4 million across 5 years, with a median of $79.1 million in 2025.
- Across the five-year window, Prepaid Assets plunged 34.72% in 2022 and soared 138.25% in 2023, its largest moves.
- Year by year, Prepaid Assets stood at $41.2 million in 2022, then soared by 138.25% to $98.2 million in 2023, then decreased by 7.01% to $91.3 million in 2024, then fell by 13.36% to $79.1 million in 2025, then gained by 29.53% to $102.4 million in 2026.
- Per Business Quant data, the three most recent Prepaid Assets figures were $102.4 million in Q1 2026, $79.1 million in Q4 2025, and $84.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Alkermes | 9.72 Bn | 9.21 Bn | 331.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 102.45 Mn |
| Dec 31, 2025 | 79.09 Mn |
| Sep 30, 2025 | 84.44 Mn |
| Jun 30, 2025 | 71.30 Mn |
| Mar 31, 2025 | 89.84 Mn |
| Dec 31, 2024 | 91.28 Mn |
| Sep 30, 2024 | 94.05 Mn |
| Jun 30, 2024 | 101.44 Mn |
| Mar 31, 2024 | 111.54 Mn |
| Dec 31, 2023 | 98.17 Mn |
| Sep 30, 2023 | 42.98 Mn |
| Jun 30, 2023 | 44.45 Mn |
| Mar 31, 2023 | 47.01 Mn |
| Dec 31, 2022 | 41.20 Mn |
| Sep 30, 2022 | 40.04 Mn |
| Jun 30, 2022 | 47.09 Mn |
| Mar 31, 2022 | 61.02 Mn |
| Dec 31, 2021 | 48.97 Mn |
| Sep 30, 2021 | 61.34 Mn |
| Jun 30, 2021 | 57.19 Mn |